Compass Therapeutics (CMPX) Return on Invested Capital (2020 - 2022)

Compass Therapeutics' Return on Invested Capital history runs 3 years deep, the most recent figure standing at 0.0% for Q3 2022.

• In Q3 2022, Return on Invested Capital changed N/A year-over-year to 0.0%; the TTM figure through Sep 2022 stood at 0.0% (changed N/A YoY), while the FY2020 annual figure was 0.01%, changed 0.0% from the prior year.
• Return on Invested Capital came in at 0.0% for Q3 2022 at Compass Therapeutics, down from 0.0% in the prior quarter.
• In the past five years, Return on Invested Capital ranged from a high of 0.01% in Q2 2020 to a low of 0.01% in Q1 2021.
• A 3-year average of 0.0% and a median of 0.0% in 2022 frame the typical range for Return on Invested Capital.
• On a YoY basis, Return on Invested Capital climbed as much as 0 bps in 2022 and fell as far as 0 bps in 2022.
• Compass Therapeutics' Return on Invested Capital stood at 0.0% in 2020, then dropped by 21 bps to 0.0% in 2021, then climbed by 18 bps to 0.0% in 2022.
• According to Business Quant data, Return on Invested Capital over the past three periods registered 0.0%, 0.0%, and 0.0% for Q3 2022, Q2 2022, and Q1 2022 respectively.

Peer Comparison